Del Carmen Jeffrey Insider Trades

Insider Trading History

Track insider trading activity for Del Carmen Jeffrey. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $449k 14,337 shares
Last Trade
Dec 29, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$92.4k 3,839 shares
$24.06
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $569k 18,176 shares
Last Trade
Dec 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 8,667 shares
$24.06
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $32.4M 1,036,846 shares
Last Trade
Dec 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$209k 8,667 shares
$24.06
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $32.7M 1,045,513 shares
Last Trade
Dec 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$189k 8,039 shares
$23.53
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $376k 12,001 shares
Last Trade
Dec 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$189k 8,039 shares
$23.53
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $298k 9,509 shares
Last Trade
Dec 08, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$58.6k 2,492 shares
$23.53
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $124k 3,962 shares
Last Trade
Nov 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$256k 10,983 shares
$23.33
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $33M 1,053,552 shares
Last Trade
Nov 26, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$515k 21,966 shares
$23.43
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $124k 3,962 shares
Last Trade
Nov 21, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$38.2k 1,641 shares
$23.28
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $175k 5,603 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$130k 5,603 shares
$23.28
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $33.3M 1,064,535 shares
Last Trade
Nov 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$130k 5,603 shares
$23.28
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $33.5M 1,070,138 shares
Last Trade
Nov 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.17M 139,130 shares
$22.77
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$696k 30,423 shares
$22.89
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $952k 30,423 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$72.7k 3,125 shares
$23.27
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $1.05M 33,548 shares
Last Trade
Feb 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$248k 10,667 shares
$23.27
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $29.1M 931,008 shares
Last Trade
Feb 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$248k 10,667 shares
$23.27
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $29.5M 941,675 shares
Last Trade
Dec 27, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$186k 8,667 shares
$21.47
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $836k 26,720 shares
Last Trade
Dec 27, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$186k 8,667 shares
$21.47
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $716k 22,881 shares
Last Trade
Dec 27, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$82.4k 3,839 shares
$21.47
$31.29
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals CPRX
Chief Commercial Officer
Holding Value $565k 18,053 shares
Last Trade
Dec 09, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$51.2k 2,355 shares
$21.74
$31.29

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up